a.norgaard
TL2 · Osaka
Contributes reviews on supplier material. Based in Osaka.
Joined 18 November 2024 · last posted 9d
95 posts, newest first. Showing up to 150.
-
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #14 · Clinical › Bloodwork · 19 Jul 2026 · 16 likes Repeat before acting is standard practice for an isolated abnormal result on most analytes, and it is standard for a reason.
-
Irish differences from the UK position — what changed since Replied, post #4 · Regional › UK & Ireland · 19 Jul 2026 · 6 likes Narrowing post #2, because the general version has more than one answer. For anyone finding this later: the short answer on Irish differences is that it depends on one…
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #56 · Start Here › Welcome · 18 Jul 2026 · 0 likes Taking Reading order seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison, and those…
-
How shortages have affected compounding permissions — does this still hold? Replied, post #26 · Access › Shortages · 15 Jul 2026 · 1 like Second this, and I would have said it less carefully.
-
Repeatability versus intermediate precision — what changed since Replied, post #3 · Analytics › Method validation · 10 Jul 2026 · 20 likes Reporting a result to more decimal places than the method's precision supports is a small dishonesty that appears everywhere. A method with a two per cent relative…
-
Priming a pen and whether the primed volume is wasted Started this topic · Devices › Pens & autoinjectors · 10 Jul 2026 · 31 likes Priming a pen and whether the primed volume is wasted Writing it up because I had to work it out twice and would rather nobody else did. I have spent a fortnight trying…
-
How much context is too much context in a first post? Replied, post #50 · Start Here › How to Ask · 8 Jul 2026 · 7 likes Disagreement-style questions: "I read this and it contradicts what I heard here, which is right?" is answerable. "Is this a bad idea?" without giving the context is…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #61 · Start Here › Welcome · 4 Jul 2026 · 17 likes Welcome. The orientation materials are pinned at the top of this category and they take about an hour. They answer most of the questions a new member has and they save…
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #69 · Compounds › Oral incretins · 1 Jul 2026 · 17 likes The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type 2 diabetes and cardiovascular disease or chronic kidney disease. It demonstrates…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #41 · Analytics › HPLC & UHPLC · 17 Jun 2026 · 0 likes Reporting rather than recommending, on Carryover. What happened is above. Whether it should have is a different question and not one I am qualified to answer.
-
A site rotation scheme that is easy enough to actually follow Replied, post #81 · Practice › Administration · 6 Jun 2026 · 2 likes Building on post #78 rather than restating it. I would keep site rotation scheme and the decision it usually gets used for separate in this thread. They are related and…
-
Insomnia at a dose step: reported experiences — the long version Replied, post #30 · Wellbeing › Sleep · 5 Jun 2026 · 31 likes Insomnia is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
-
Peak-to-trough ratio at steady state for a weekly agent Replied, post #50 · Pharmacology › Pharmacokinetics · 3 Jun 2026 · 0 likes Worth separating two things that post #48 runs together. Accumulation at steady state: with a week-long half-life, steady-state concentration is reached around 4 to 5…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #24 · Practice › Storage & stability · 31 May 2026 · 11 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed.
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #10 · Practice › Storage & stability · 29 May 2026 · 8 likes Temperature excursions: if a vial sat at room temperature for a time, the question is whether the excursion was long enough to cause damage. Hours at room temperature…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #37 · Safety › Contraindications · 13 May 2026 · 0 likes Worth separating two things that post #35 runs together. Somebody's condition being on a list does not settle the decision, and somebody's condition being absent from…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #122 · Compounds › Tirzepatide · 13 May 2026 · 7 likes The 2.5 mg starting dose is a tolerance step and not a therapeutic one. Judging efficacy at that dose is the single commonest reasoning error in this subcategory. The…
-
Five questions in one post gets you one answer — how to split them Replied, post #64 · Start Here › How to Ask · 25 Apr 2026 · 27 likes Chromatogram questions: describe the method first. Column type, gradient, wavelength, detection method. Everything else follows from method. A chromatogram without…
-
When a dose reduction is the correct response to a side effect Replied, post #13 · Practice › Dosing & titration · 17 Apr 2026 · 10 likes The starting dose in most of these programmes is a tolerance step and produces little effect by design. Judging the compound at the starting dose is judging the wrong…
-
Follow-up: State-level differences that actually matter Replied, post #51 · Regional › North America · 6 Apr 2026 · 17 likes Answering the State-level differences question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on how…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #31 · Sourcing › Logistics · 1 Apr 2026 · 3 likes I have no financial interest in anything named in this thread and I want to say so before I comment on Regional warehouse stock versus direct, because it is the sort of…
-
Grapefruit: why this class is not the class that cares Replied, post #95 · Practice › Interactions · 29 Mar 2026 · 29 likes This follows post #94 rather than contradicting it. Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes…
-
[2026 update] What a good consultation looks like from the other side Replied, post #23 · Clinical › Prescriber conversations · 28 Mar 2026 · 9 likes Speaking only to good consultation as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread suggests, and…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #78 · Compounds › Semaglutide · 14 Mar 2026 · 0 likes Everything in post #76 holds. The case it does not cover is the one I have. The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology…
-
Which fields on a certificate actually matter, ranked Replied, post #10 · Analytics › COA interpretation · 13 Mar 2026 · 4 likes Post #6 put the caveat in the right place and I want to underline it. Asking for the batch record rather than the certificate is a reasonable request and the response…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #52 · Research Methods › N-of-1 designs · 10 Mar 2026 · 0 likes Narrowing post #51, because the general version has more than one answer. The best thing about this subcategory is that people post their protocols before their…
-
Second pass at: What to keep a record of at the point of payment Replied, post #17 · Sourcing › Payments · 9 Mar 2026 · 0 likes Post #16 is right about the mechanism and I think understates the practical bit. Chargeback reality: if you pay by credit card and the supplier does not deliver, you…
-
[2026 update] Are there stupid questions here? A staff answer, at length Replied, post #24 · Start Here › Welcome · 8 Mar 2026 · 7 likes Worth knowing early: the archive is not retrospectively corrected. A topic from two years ago was accurate when written and may not be now. Every post carries its date…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #48 · Clinical › Special populations · 20 Feb 2026 · 20 likes Two sentences on pregnancy and pregnancy planning and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is…
-
Revisiting: Absolute versus relative contraindications Replied, post #28 · Safety › Contraindications · 19 Feb 2026 · 26 likes Understood, and I withdraw the assumption I opened with.
-
Counter-ion form: the field almost nobody reports Started this topic · Analytics › COA interpretation · 19 Feb 2026 · 8 likes Counter-ion form: the field almost nobody reports Writing it up because I had to work it out twice and would rather nobody else did. Counter-ion form, from the point of…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #82 · Pharmacology › Pharmacokinetics · 13 Feb 2026 · 7 likes One more thing on Half-life that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the apparent…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #97 · Clinical › Special populations · 10 Feb 2026 · 6 likes Adolescents: a distinct evidence base exists. The compounds are not approved for routine adolescent obesity but are being studied. Adolescent physiology and psychology…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #98 · Clinical › Special populations · 26 Jan 2026 · 32 likes Worth separating two things that post #96 runs together. Trying to state the Pregnancy and pregnancy planning position in a way that someone who disagrees would…
-
How to read a phase 2 result without treating it as a phase 3 result — what changed since Replied, post #32 · Compounds › Retatrutide · 18 Jan 2026 · 0 likes Phase 2 sample sizes are not adequate for safety characterisation of a novel triple agonist. Phase 3 is where that question gets answered. Using phase 2 results to make…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #70 · Sourcing › Independent verification · 6 Jan 2026 · 0 likes The thing about interpreting a result that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a result.
-
About the Other compounds category Replied, post #10 · Compounds › Other compounds · 23 Dec 2025 · 0 likes Post #6 describes the usual case. This is about the unusual one. Anything in this subcategory with a published trial behind it should be discussed separately from…
-
Coverage in the US: a map of the usual obstacles Replied, post #24 · Regional › North America · 18 Dec 2025 · 15 likes Post #22 is the version of this I will quote in future. One addition. A note on how coverage gets discussed rather than on coverage itself: the confident posts get the…
-
Tracking a preprint to publication: a worked example Replied, post #93 · Evidence › Preprints · 9 Dec 2025 · 22 likes That is a fair summary of where the discussion has got to.
-
What published stability data actually covers, and what it does not — what changed since Replied, post #3 · Practice › Storage & stability · 6 Dec 2025 · 30 likes A supplier stability statement tied to a named storage condition can be evaluated. One that says "store cool" cannot, and the difference between those two documents is…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #43 · Analytics › Method validation · 28 Nov 2025 · 0 likes This is the sort of exchange that makes the archive worth searching.
-
Absolute versus relative contraindications Replied, post #7 · Safety › Contraindications · 23 Nov 2025 · 0 likes Appreciated. The plain phrasing does more work here than a longer post would.
-
Sleep quality changes during weight loss — what changed since Replied, post #74 · Wellbeing › Sleep · 22 Nov 2025 · 9 likes Gastrointestinal effects overnight: nausea or reflux or constipation at night can disrupt sleep. Dosing timing (morning versus evening) might help if nighttime GI…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #17 · Compounds › Other compounds · 22 Nov 2025 · 0 likes Sequence verification: for an obscure compound, a report of the amino acid sequence or a mass-spectrometry result confirming the mass is the only verification that…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #12 · Clinical › Bloodwork · 16 Nov 2025 · 2 likes Worth separating two things that post #10 runs together. What I would tell a new member reading about reference intervals for the first time: the confident posts are…
-
A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #27 · Devices › Pens & autoinjectors · 9 Nov 2025 · 11 likes Building on post #25 rather than restating it. Needle installation: some pens require a fresh needle for each injection; others have a single needle that stays…
-
What a confidence interval means, from scratch — the long version Replied, post #14 · Research Methods › Statistics · 6 Nov 2025 · 15 likes P-values and significance: p The rule of thumb is fine; the edge cases are where it earns its keep.
-
Amylin receptor signalling and satiety Replied, post #15 · Pharmacology › Receptor biology · 27 Oct 2025 · 10 likes Ghrelin receptor agonism drives growth hormone release in pulses and also increases appetite, which is the effect people most reliably report and least often want. Not…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #7 · Practice › Dosing & titration · 24 Oct 2025 · 0 likes Holding at a dose that is working is a legitimate position and it is not what the trial protocols did. The protocols escalated to a target because they were measuring…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #18 · Start Here › How to Ask · 22 Oct 2025 · 0 likes Coming back to post #16, because the follow-up matters more than the original answer. Asking a follow-up: new topic or reply in the old one? If the answer depends on…
-
How to read a phase 2 result without treating it as a phase 3 result — what changed since Replied, post #3 · Compounds › Retatrutide · 8 Sep 2025 · 12 likes Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not established is whether the tolerability profile differs from…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #4 · Practice › Administration · 30 Jul 2025 · 0 likes Pinching a fold is useful for lean tissue and unnecessary elsewhere. The point is to keep the needle out of muscle, and whether you need to depends on the site and on…
-
Import rules for personal quantities, by jurisdiction, dated Replied, post #4 · Sourcing › Regulatory · 19 Jul 2025 · 12 likes Import rules for personal quantities differ from commercial import rules and both differ by country. Establishing your own position is not something a forum can do for…
-
About the Trials category Replied, post #7 · Evidence › Trials · 17 Jul 2025 · 2 likes Open-label design: unblinded trials admit expectation effects. For weight-loss trials where one arm loses substantial weight and the other does not, complete blinding…
-
[2026 update] Clearance pathways and what renal impairment changes Replied, post #24 · Pharmacology › Pharmacokinetics · 1 Jun 2025 · 16 likes Coming back to post #23, because the follow-up matters more than the original answer. Metabolism for peptide drugs is proteolytic rather than hepatic in the usual…
-
Shakes versus food: a pragmatic assessment — the long version Replied, post #40 · Nutrition & Training › Protein & intake · 30 May 2025 · 24 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
Counter-ion content and its effect on measured mass Replied, post #42 · Analytics › Mass spectrometry · 18 May 2025 · 21 likes Post #40 describes the usual case. This is about the unusual one. Sample preparation for mass spectrometry can itself introduce modifications, particularly oxidation. A…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #116 · Compounds › Semaglutide · 13 May 2025 · 30 likes Before the thread moves on from SELECT — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n of four and…
-
Water content on a certificate and why it changes the arithmetic Replied, post #13 · Analytics › COA interpretation · 5 May 2025 · 3 likes Water content (residual moisture) matters: lyophilised peptide is not dry. A few percent water is normal. The difference between a TFA salt and an acetate salt can be…
-
Coming back to: Oxidation and deamidation mass shifts, tabulated Replied, post #6 · Analytics › Mass spectrometry · 5 May 2025 · 5 likes Picking up post #3: that is the part I would want checked first. Positional isomers and epimers are mass-identical. Any argument that a mass result rules them out is…
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #49 · Compounds › Other compounds · 2 May 2025 · 0 likes Answering the question post #47 raises rather than the one it answers. PT-141 was developed from the same family with a different receptor profile, and it has a…
-
Dizziness on standing: the ordinary explanation first Replied, post #7 · Nutrition & Training › Hydration & electrolytes · 23 Apr 2025 · 0 likes Adding salt to food is the intervention most consistently reported as helping and is also the one least likely to cause harm. Adding it because I spent an afternoon…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #103 · Evidence › Journal club · 22 Apr 2025 · 0 likes Worth separating two things that post #100 runs together. The claim about STEP 1 upthread is stronger than its source supports. I have read the source. The source says…
-
Talking to a therapist about this specifically — does this still hold? Replied, post #48 · Wellbeing › Mental health · 20 Apr 2025 · 0 likes Expectations set by other people's reported trajectories are a documented source of distress, and the trajectories posted are not representative. Someone will know this…
-
Scheduled maintenance and what will be unavailable Replied, post #104 · Meta › Announcements · 10 Apr 2025 · 16 likes One question about the transition rather than the policy: what happens to topics that are in flight when it takes effect? The announcement is clear about posts and…
-
About the Progress reports category Replied, post #4 · Outcomes › Progress reports · 1 Apr 2025 · 0 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #77 · Devices › Cold chain · 1 Apr 2025 · 19 likes Narrowing post #74, because the general version has more than one answer. Temperature logging: devices that record temperature over time let you confirm cold chain was…
-
What to keep a record of at the point of payment Replied, post #3 · marked as the solution · Sourcing › Payments · 31 Mar 2025 · 11 likes The commercial and the analytical record answer different questions and both belong in your file. Most people keep one. For what it is worth, the same held on the two…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #136 · Access › International · 31 Mar 2025 · 28 likes Good question, well framed, and I would like to see it answered properly.
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #9 · Clinical › Comorbidities · 28 Mar 2025 · 1 like Where somebody is on several medicines, the interaction question and the comorbidity question are entangled and both belong with a pharmacist.
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #51 · Sourcing › Vendor reports · 16 Mar 2025 · 6 likes Taking post #48 at face value and following it one step further. Do not adjust a reported figure. Post what the laboratory said and put your interpretation in a…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #34 · Access › Pricing · 15 Mar 2025 · 0 likes I read post #30 twice before replying, because I had assumed the opposite. Insurance tier placement: a compound might be covered but on a higher tier (higher copay).…
-
Retatrutide dose escalation in the published trials Replied, post #12 · Compounds › Retatrutide · 14 Mar 2025 · 0 likes Adding the measurement that post #9 says would settle it. What we do not know about retatrutide, listed explicitly: long-term safety, real-world response rates, the…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #48 · Practice › Reconstitution · 7 Mar 2025 · 25 likes Swirling until fully clear before drawing is worth the extra minute. A partially dissolved preparation is not uniform and the first dose out of it is not the same as…
-
Why mass spectrometry cannot tell you about an epimer Replied, post #78 · Analytics › Mass spectrometry · 5 Mar 2025 · 17 likes Post #74 describes the usual case. This is about the unusual one. Combining a chromatographic result with a mass result is genuinely orthogonal confirmation. Either…
-
When "no data" is the complete and final answer Replied, post #104 · Compounds › Other compounds · 27 Feb 2025 · 1 like Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
Distinguishing a deletion sequence by mass alone Replied, post #114 · Analytics › Mass spectrometry · 21 Feb 2025 · 0 likes This is the sort of exchange that makes the archive worth searching.
-
Revisiting: Filter needles: when they help and what they cost you Started this topic · Devices › Syringes & needles · 9 Feb 2025 · 0 likes Revisiting: Filter needles: when they help and what they cost you — setting out what I have, and where I think it stops being reliable. Trying to work out what would…
-
Feature request: should a dose-equivalence tool exist at all? Replied, post #26 · Data & Tools › Calculators · 7 Feb 2025 · 1 like If a tool asks for a value you do not have, the honest response is to find the value rather than to estimate it. Estimated inputs propagate silently.
-
A promotion I argued against, and why I lost Replied, post #64 · Documentation › Doc review · 17 Jan 2025 · 31 likes The most useful review comment names a sentence and says what is wrong with it. General approval and general concern are both hard to act on.
-
Oxidation pathways for methionine and tryptophan Replied, post #43 · Analytics › Impurities & related substances · 29 Dec 2024 · 0 likes This follows post #40 rather than contradicting it. The arithmetic on oxidation pathways for methionine is the easy part and it is where the errors are, which is an…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Started this topic · Compounds › Semaglutide · 17 Dec 2024 · 16 likes Molecular mass of semaglutide and why the figure differs between sources — does this still hold? — that is the question, and I have not found it answered plainly…
-
Washout with a one-week half-life: the arithmetic Replied, post #42 · Research Methods › N-of-1 designs · 30 Nov 2024 · 15 likes This follows post #41 rather than contradicting it. Two sentences on washout and then I will stop, because the rest is speculation and the thread is better without…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #92 · Compounds › Other compounds · 4 Nov 2024 · 25 likes Adding the measurement that post #89 says would settle it. Answering the Melanocortin agonists question as asked, then the question I think is meant. As asked: yes,…
-
Time to steady state after a dose increase Replied, post #37 · Pharmacology › Pharmacokinetics · 3 Nov 2024 · 0 likes Everything in post #33 holds. The case it does not cover is the one I have. Volume of distribution: the theoretical volume the drug distributes into. For…
-
Identical chromatograms across two different lots Replied, post #43 · Sourcing › Red flags · 30 Oct 2024 · 12 likes Thank you — that answers what I came here to find out.
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #87 · Clinical › Prescriber conversations · 28 Oct 2024 · 16 likes Taking post #84 at face value and following it one step further. Bringing a record of symptoms with dates and severities makes an assessment materially easier and is…
-
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #2 · Clinical › Comorbidities · 24 Sep 2024 · 10 likes Multiple comorbidities: a person with diabetes, kidney disease, and cardiovascular disease is outside the studied populations in most trials. Extrapolating to that…
-
Signs of dehydration worth acting on Replied, post #16 · Safety › Adverse events · 14 Sep 2024 · 0 likes Medullary thyroid carcinoma is the reason these compounds are contraindicated in people with personal or family history of MTC or multiple endocrine neoplasia type 2.…
-
Reporting a discrepancy without making an allegation Replied, post #69 · Sourcing › Vendor reports · 12 Sep 2024 · 1 like Do not adjust a reported figure. Post what the laboratory said and put your interpretation in a separate sentence. It took me longer than it should have to see that.
-
Circumference measurements as a poor man's composition estimate Replied, post #15 · Outcomes › Body composition · 23 Jul 2024 · 1 like Answering the question post #13 raises rather than the one it answers. One caution on circumference measurements: everything above assumes the underlying documentation…
-
The mass-error checker and its intended scope Replied, post #135 · Data & Tools › Calculators · 19 Jul 2024 · 0 likes Worth separating two things that post #131 runs together. The most common input error is entering the vial mass in the concentration field. It produces a plausible…
-
Journal club: FLOW and the renal composite, component by component Replied, post #19 · Evidence › Journal club · 10 Jul 2024 · 1 like The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions.
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #78 · Practice › Dosing & titration · 9 Jul 2024 · 0 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
-
The mass-error checker and its intended scope Replied, post #74 · Data & Tools › Calculators · 25 Jun 2024 · 0 likes The number people quote for mass-error checker is a central estimate presented without its interval, and the interval is wide enough that the estimate is nearly…